| 2021.01.22~2021.03.05 |
Antiviral testing of nanoparticles |
| 2021.04.28~2021.06.22 |
Antiviral testing in aerosol conditions of virus fluid |
| 2021.02.22~2021.03.29 |
Antiviral testing of silver nanomaterials |
| 2021.03.02~2021.06.04 |
Toxicity and efficacy testing of PCN1801 (peptide mimetic) |
| 2021.04.01~2021.06.03 |
Efficacy testing of gastroscopy disinfectants |
| 2021.04.26~2021.05.31 |
Antiviral testing of silicon films |
| 2021.05.24~2021.08.16 |
Antiviral testing of natural product extracts |
| 2021.06.01~2021.08.03 |
Antiviral testing and inhibition test of natural products in HPV-positive cell line |
| 2021.06.14~2021.08.09 |
Antiviral testing of ClO2 gel |
| 2021.10.22~2021.12.18 |
Antiviral testing of chemical disinfectants |
| 2021.11.02~2021.12.03 |
Antiviral testing of marine materials |
| 2021.11.15~2022.11.15 |
Development of pH-responsive hydrogel and its capsulation |
| 2021.12.01~2022.01.28 |
In vivo efficacy testing of fermented rice extracts for intestinal health |
| 2021.11.04~2022.04.29 |
In vivo efficacy testing of silkworm for HFD & STZ-induced diabetes model |
| 2021.01.03~2021.01.24 |
Antibacterial and antifungal testing of chemical disinfectants |
| 2022.09.26~2022.12.12 |
In vivo efficacy testing of drug candidates for DEX-induced sarcopenia model |
| 2022.04.29~2022.11.30 |
Antiviral testing of marine protein extracts |
| 2022.09.19~2022.11.30 |
Lactic acid bacteria growth and bone health functionality test of fermented milk |
| 2022.06.20~2022.11.20 |
Antiviral testing of car interior materials |
| 2022.04.15~2022.06.30 |
Cytotoxicity testing of oncolytic viruses |
| 2022.07.01~2022.07.29 |
Antibacterial testing of pine oil as a chemical disinfectant |
| 2022.09.15~2022.11.30 |
Antiviral testing of chemical disinfectants against airborne coronavirus |
| 2023.01.30~2023.05.30 |
In vivo efficacy testing of medicinal herbal extracts for HFD-induced obesity model |
| 2023.03.01~2023.05.31 |
In vivo efficacy testing of natural anthocyanin extracts for intestinal health and antiviral testing |
| 2023.04.24~2023.07.17 |
In vitro testing of natural extracts for anti-inflammation, moisturizing, and anti-wrinkle effects |
| 2023.05.03~2023.08.30 |
In vitro efficacy testing of anti-aging materials |
| 2023.06.13~2023.10.26 |
Antiviral testing of natural product extracts and its indicative substance |
| 2023.06.28~2023.08.23 |
Antibacterial testing of a core-shell microcapsule consisting of natural products |
| 2023.07.25~2023.10.31 |
In vivo efficacy testing of probiotics for adenine-induced renal injury model |
| 2023.07.24~2023.10.30 |
Antiviral efficacy testing of 3 drug candidates in HCoV 220E virus |
| 2023.08.10~2023.10.30 |
In vitro and in vivo efficacy testing of natural products for skin health (moisturizing) |
| 2023.08.30~2023.10.20 |
Antiviral testing of natural products |
| 2023.09.15~2023.11.23 |
Antiviral testing of marine extracts for Dengue virus |
| 2023.10.11~2023.12.31 |
Pharmokinetic analysis of antiviral drug candidates |
| 2023.11.29~2024.03.31 |
Antibacterial & antifungal testing of Cudrania tricuspidata |
| 2023.11.30~2024.04.30 |
In vivo efficacy testing of *** extracts for HFD-induced obesity model |
| 2024.01.02~2024.02.29 |
In vitro efficacy testing of *** extracts in preadipocyte model |
Bio-analysis service
